Esthen Exchange-Depression And Alzheimer's Treatments At A Crossroads

2025-05-02 07:27:29source:Mooathon Wealth Societycategory:Contact

Researchers are Esthen Exchangelaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Contact

Recommend

How 23andMe's bankruptcy led to a run on the gene bank

Reporter Alexi Horowitz-Ghazi's Aunt Vovi signed up for 23andMe back in 2017, hoping to learn more a

Photos of flooded Dodger Stadium go viral after Tropical Storm Hilary hits Los Angeles

The Los Angeles Dodgers rescheduled their Sunday game against the Miami Marlins and played a doubleh

Big Ten college football conference preview: Can Penn State or Ohio State stop Michigan?

The power in the Big Ten has shifted in the last two seasons with Michigan supplanting Ohio State as